Eccrine squamous syringometaplasia associated with sunitinib therapy.
Sheen
Y-S
YS
Huang
C-L
CL
Chu
C-Y
CY
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004439:Eccrine Glands; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib; D013544:Sweat Gland Neoplasms / Q000139:chemically induced*; D018252:Syringoma / Q000139:chemically induced*
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib